Merit Medical Systems, Inc. $MMSI Shares Purchased by Quantinno Capital Management LP

Key Points

• Quantinno Capital Management increased its Merit Medical Systems stake by 200.3% in the first quarter, owning 17,612 shares valued at approximately $1.21 million. Institutional investors and hedge funds collectively own 99.66% of MMSI.
• Analyst sentiment remains positive, with eight Buy ratings and four Holds producing a consensus “Moderate Buy” rating and an average price target of $100. Several firms recently raised their targets, including Needham to $101 and Canaccord Genuity to $94.
• Merit Medical exceeded quarterly expectations, reporting $1.19 in EPS versus the $0.96 consensus and revenue of $418.84 million, up 9.5% year over year. Shares opened at $90.76, near the company’s 52-week high of $94.75.

Quantinno Capital Management LP raised its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 200.3% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,612 shares of the medical instruments supplier's stock after purchasing an additional 11,747 shares during the quarter. Quantinno Capital Management LP's holdings in Merit Medical Systems were worth $1,214,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of MMSI. AQR Capital Management LLC lifted its holdings in shares of Merit Medical Systems by 7.3% in the first quarter. AQR Capital Management LLC now owns 16,361 shares of the medical instruments supplier's stock valued at $1,730,000 after buying an additional 1,114 shares during the period. Goldman Sachs Group Inc. boosted its stake in Merit Medical Systems by 16.9% during the first quarter. Goldman Sachs Group Inc. now owns 719,313 shares of the medical instruments supplier's stock valued at $76,039,000 after buying an additional 103,878 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in Merit Medical Systems by 745.9% during the second quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier's stock valued at $86,000 after buying an additional 813 shares in the last quarter. First Trust Advisors LP grew its holdings in Merit Medical Systems by 24.8% during the second quarter. First Trust Advisors LP now owns 59,215 shares of the medical instruments supplier's stock worth $5,535,000 after acquiring an additional 11,770 shares during the period. Finally, Cerity Partners LLC raised its position in Merit Medical Systems by 9.1% in the second quarter. Cerity Partners LLC now owns 3,019 shares of the medical instruments supplier's stock worth $282,000 after acquiring an additional 251 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on MMSI shares. Canaccord Genuity Group upped their price target on shares of Merit Medical Systems from $85.00 to $94.00 and gave the company a "buy" rating in a report on Friday, July 31st. Needham & Company LLC lifted their price objective on shares of Merit Medical Systems from $90.00 to $101.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. Barrington Research set a $114.00 target price on shares of Merit Medical Systems in a report on Friday, July 31st. Weiss Ratings raised shares of Merit Medical Systems from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Monday, August 3rd. Finally, Bank of America raised their target price on shares of Merit Medical Systems from $92.00 to $97.00 and gave the stock a "neutral" rating in a report on Thursday. Eight research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Merit Medical Systems has a consensus rating of "Moderate Buy" and an average price target of $100.00.

Merit Medical Systems Stock Performance

Merit Medical Systems stock opened at $90.76 on Friday. The firm's 50 day simple moving average is $75.05 and its 200-day simple moving average is $72.25. The company has a market cap of $5.42 billion, a P/E ratio of 37.50, a price-to-earnings-growth ratio of 2.28 and a beta of 0.49. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. Merit Medical Systems, Inc. has a fifty-two week low of $59.74 and a fifty-two week high of $94.75.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.23. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The business had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. During the same quarter in the previous year, the business earned $1.01 earnings per share. The firm's revenue was up 9.5% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities research analysts predict that Merit Medical Systems, Inc. will post 3.81 EPS for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source